跳至主要内容
临床试验/NCT03266081
NCT03266081撤回2 期

Improving Epiphora & Ptosis With Bupivacaine

McMaster University1 个研究点 分布在 1 个国家开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Change from Baseline Lacrimal Tear Lake at 6 months

研究概览

简要总结

The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients age 18 and above, patients with unilateral or bilateral excessive tearing.

排除标准

  • Pregnant females, vulnerable populations, patients with severe hepatic disease, or patients using monoamine oxidase inhibitors or tricyclic antidepressants, which are contraindicated with bupivacaine and norepinephrine combinations.

研究组 & 干预措施

0.75% bupivacaine

Experimental

干预措施: 0.75% bupivacaine (Drug)

结局指标

主要结局

Change from Baseline Lacrimal Tear Lake at 6 months

时间窗: measurements at baseline and 6 months

Measurement of the height (in mm) of the tear film in the lower conjunctival cup de sac, obtained during slit lamp examination of the eye

次要结局

  • Change from baseline Lid distraction at 6 months(measurements at baseline and 6 months)
  • Change from baseline Lid snap back at 6 months(measurements at baseline and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Albert Wu

Assistant Professor, Ophthalmology

Stanford University

研究点 (1)

Loading locations...

相似试验